L.A. area's Kite Pharma could score big with new cancer treatment
Source: BY STUART PFEIFER, LA Times
October 17, 2015, 2:00 p.m.
Kite Pharma, one of the hottest biotech start-ups on Wall Street, hopes to revolutionize the treatment of a common, deadly lymphatic cancer with a novel mix of highly trained lab techs and high-speed air travel.
The Santa Monica company's treatment of non-Hodgkin's lymphoma reprograms a patient's T-cells the kind that are supposed to fight disease to seek and destroy only abnormal, cancerous lymph cells, not the healthy ones crucial for human life.
But in order to do so, blood must be drawn from a patient, refrigerated and flown to Kite's headquarters, where the cells are modified, frozen and then flown back to doctors who re-inject them into patients.
Dr. Arie Belldegrun, Kite's founder and chief executive, likens the two-week process to installing a navigation system in a car.
<>
"We have seen tumors that originally failed every possible known treatment disappearing within weeks from the infusion," Belldegrun said. "Tumors were melting away."
Read more: http://touch.latimes.com/#section/1780/article/p2p-84735224/
7962
(11,841 posts)packman
(16,296 posts)Little Tich
(6,171 posts)appalachiablue
(41,131 posts)FormerRepublicanNow
(43 posts)Galileo126
(2,016 posts)appalachiablue
(41,131 posts)with Matt Damon and Jody Foster that came out a year or so ago. Pretty grim.
Califonz
(465 posts)But they went bankrupt because the course treatment cost almost $100,000 and other companies developed vastly cheaper alternative drugs.
it's the car t treatment. they take t cells from the patient and genetically engineer them to develop car receptors that recognize antigens from the tumors. they then reinsert the t cells into the blood in order to hunt and kill these cancer cells.
so far it's only proven to work on liquid tumors. and yes it's very expensive since it's personalized medicine. it's very experimental and a last line of treatment.